Multiple drugsCardiac toxicities following off-label treatment: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1823卷 / 1期

关键词：

D O I：

10.1007/s40278-020-83873-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：245 / 245

相关论文

共 50 条

[31] RituximabVarious toxicities following off-label use: 8 case reports
[J]. Reactions Weekly, 2017, 1669 (1) : 234 - 234
[32] RituximabVarious toxicities following off-label use: 2 case reports
[J]. Reactions Weekly, 2020, 1834 (1) : 234 - 234
[33] RituximabVarious toxicities and off-label use: 3 case reports
[J]. Reactions Weekly, 2023, 1940 (1) : 374 - 374
[34] Multiple drugsVarious toxicities, lack of efficacy and off-label use: 3 case reports
[J]. Reactions Weekly, 2022, 1894 (1) : 244 - 244
[35] Multiple drugsVarious toxicities and off-label use: 37 case reports
[J]. Reactions Weekly, 2023, 1964 (1) : 325 - 325
[36] PembrolizumabVarious toxicities following off-label use: 4 case reports
[J]. Reactions Weekly, 2018, 1692 (1) : 286 - 286
[37] TemsirolimusVarious toxicities following off-label use: 8 case reports
[J]. Reactions Weekly, 2021, 1869 (1) : 328 - 328
[38] InotersenMultiple toxicities following off-label use: 6 case reports
[J]. Reactions Weekly, 2021, 1852 (1) : 239 - 239
[39] TocilizumabVarious toxicities following off-label use: 4 case reports
[J]. Reactions Weekly, 2023, 1944 (1) : 529 - 529
[40] MemantineVarious toxicities following off-label use: 8 case reports
[J]. Reactions Weekly, 2021, 1867 (1) : 246 - 246

← 1 2 3 4 5 →